Protein solution viscosity

Protein solution viscosity is a fundamental biophysical property that characterizes the resistance to flow of a liquid formulation containing proteins, such as monoclonal antibodies. It is not a biological molecule or a therapeutic target; rather, it is a critical developability parameter in the pharmaceutical industry, especially for high-concentration subcutaneous biologics. High viscosity often arises when protein concentrations exceed 100 mg/mL, where molecular crowding and specific protein-protein interactions (PPI)—including electrostatic and hydrophobic forces—lead to the formation of transient networks or clusters. In a clinical context, excessive solution viscosity can impair the syringeability of a drug, necessitating larger needles or higher injection forces, which can cause patient discomfort or lead to device failure. In pathology, elevated serum or plasma viscosity is the hallmark of hyperviscosity syndrome, often resulting from high levels of monoclonal proteins in conditions like Waldenström's macroglobulinemia. Formulation scientists manage viscosity by optimizing pH and utilizing excipients such as arginine or salts to disrupt the molecular interactions that drive the viscous state.

Other names

Solution viscosityBulk viscosityDynamic viscosityProtein formulation viscositySerum viscosity

Reduction of protein-protein interactions (PPI) and molecular crowding through electrostatic charge screening and hydrophobic association interference.